The objectives of this study were to assess the expression of PAFR and the concentration of Lyso-PAF isoforms in the NP of patients suffering from CRS with/without comorbidities (e.g., asthma and N-ERD) compared to the NM from healthy subjects. This evidence concerns the gene PTAFR and asthma.